Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.

Xuejiao Zhang

Ying Shi

Hanyu Yang

Yi Mi

Qingzhi Gao

Yuxiu Ma

Yujie Chen

Xiaozhuo Chen

Min Bai

Guorui Mi

Xuliang Wang

Qian Guo

Yan Zhang

Bing Wei

Hui An

Denghuang Gong

Jieqiong Kang

Peipei Zhao

Chunhua Jiang

Chuanwu Zhao

Jinlu Yang

Miaomiao Wei

A compound represented by formula (I) or a tautomer, optical isomer, deuterated substance, oxynitride, solvate, pharmaceutically acceptable salt or prodrug thereof can be used in preparing a pharmaceutical composition. The compound or the pharmaceutical composition can be used in the preparation a drug for the prevention and/or treatment of cancer, tumors, viral infections, depression, neurological disorders, trauma, age-related cataracts, organ transplant rejection or autoimmune diseases.

Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof

A compound represented by formula (I) or a tautomer, an optical isomer, a nitrogen oxide, a solvate, a pharmaceutically acceptable salt or prodrug thereof are useful for treating or relieving an HIF-related and/or EPO-related disease or condition in patient. The preparation method for the compound, and use of a drug composition containing the compound and the compound or the drug composition in preparation of a drug are also provided.

1,7-naphthyridine derivative and preparation method and use therefor

The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R, Z and Q are as described in the description. 

Benzamide derivative

Growing community of inventors

Hebei, China

Xuejiao Zhang